Navigation Links
Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
Date:11/30/2009

/IV) Graft versus Host Disease. ATIR(TM) thereby significantly improves the outcome of the transplant procedure. Moreover, it enables the use of a mismatched, related (haplo-identical) donor, thus providing virtually everyone with an immediately available donor and treatment, thereby addressing a high unmet medical need as patients eligible for an allogeneic transplantation but without a matched donor available in general have no treatment options left.

ATIR(TM) has been granted orphan drug designations from both the FDA and the EMEA.

About Kiadis Pharma

Kiadis Pharma is an oncology focused biopharmaceutical development company with cell based products in clinical development. The company develops products that offer novel treatment options for terminally ill cancer patients and address significant unmet medical needs. The key focus indication for Kiadis Pharma is limitations and complications of bone marrow transplantation procedures. Kiadis Pharma is located in Amsterdam, The Netherlands. For more information about Kiadis Pharma, please visit http://www.kiadis.com.

English release is provided by Kiadis Pharma. Equivalent translations are from a third party.

SOURCE Kiadis Pharma


'/>"/>
SOURCE Kiadis Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc
2. Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
3. EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation
4. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
5. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
6. Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations
7. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
8. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
11. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014 Automated cell culture systems are ... cell culture. They allow production of optimum cells at ... in drug discovery and industries and biopharmaceutical companies. Cell ... iPSC research, cryobanking, cell-based assays, and cellular expression systems ... Analysts forecast the Global Cell Culture market ...
(Date:7/22/2014)... July 22, 2014 Rice ... at the 2014 NCSL International Workshop and Symposium ... will feature CONDEC pressure instrumentation, OIML M1 weights, ... the new, customized sets, Essential Weights™. , NCSL ... cooperative efforts in solving the common problems faced ...
(Date:7/22/2014)... Chicago, IL (PRWEB) July 22, 2014 ... will a clear and concise visual representation of history, ... Mr. Novak was always regaled by family history stories ... historic location as the "old country." Pictures and 8mm ... and undiscovered side of the family, and Steve ordered ...
(Date:7/22/2014)... July 22, 2014 Two new members ... of Directors at its annual Shareholders Meeting on June ... Officer of The PFM Group, and Stephen T. Zarrilli, ... also announced the election of Michael A. DiPiano, Managing ... Chair and Richard P. Jaffe, Esq., of Duane Morris ...
Breaking Biology Technology:Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4Rice Lake Weighing Systems Showcases Metrology Solutions for the 2014 NCSL International Workshop & Symposium 2DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 2DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 3DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 4Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3
... - A new technique inspired by elegant pop-up books ... to be mass-produced by the sheet. Devised by ... enables the rapid fabrication of not just microrobots, but ... 18 layers of carbon fiber, Kapton (a plastic film), ...
... Healthcare organizations are becoming more efficient and effective ... more connected patient care environment. But to have this ... the electronic medical record (EMR) and enterprise content management ... leader in ECM for healthcare , has a ...
... A protein that has shown early promise in preventing the ... has been found in a new study to be a key ... protein biglycan needs to be present to stabilize synapses at the ... Brown University that appears in the Feb. 14, 2012, issue of ...
Cached Biology Technology:In new mass-production technique, robotic insects spring to life 2In new mass-production technique, robotic insects spring to life 3Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System 2Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System 3When nerve meets muscle, biglycan seals the deal 2
(Date:7/22/2014)... researchers in modifying properties of nanomaterials for application in ... to recent innovative studies conducted by scientists from the ... of a simple, efficient and low cost technique involving ... by Professor Sow Chorng Haur from the Department of ... the properties of two different types of materials can ...
(Date:7/22/2014)... Stem cells offer much promise for treating damaged organs ... survival is poor, limiting their effectiveness. New methods are ... optimize their therapeutic function after transplantation, as described in ... a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ... Open Access website . , In ...
(Date:7/22/2014)... DURHAM, N.C. In a cost-effectiveness analysis of commercial ... the drug Qsymia showed the best value for the ... loss, but was also the most expensive option tested, ... Graduate Medical School. , The findings, published in the ... important information on the health and weight-loss benefits per ...
Breaking Biology News(10 mins):NUS scientists use low cost technique to improve properties and functions of nanomaterials 2NUS scientists use low cost technique to improve properties and functions of nanomaterials 3Study compares cost-effectiveness of weight-loss programs and drugs 2Study compares cost-effectiveness of weight-loss programs and drugs 3
... to save Australia’s iconic Tasmanian devils from the deadly ... Livestock Industries’ Australian Animal Health Laboratory (AAHL), Textiles and ... to hunt down the cause of Devil Facial Tumour ... infected animals. , DFTD is infectious and ...
... markers in the DNA of people with and ... researchers to identify a common gene that appears ... disease. The finding, announced today by researchers at ... Institute, Kronos Science Laboratory and their collaborative partners, ...
... dioxide emissions, but scientists at UC Irvine have determined ... explain one-third or more of the Arctic warming primarily ... soot from tailpipes, smoke stacks and forest fires enters ... is darker than natural snow. Dark surfaces absorb sunlight ...
Cached Biology News:CSIRO scientists join fight to save 'Tassie devil' 2Research team identifies new Alzheimer's gene 2Research team identifies new Alzheimer's gene 3Dirty snow may warm Arctic as much as greenhouse gases 2
... that made the original Gene Pulser apparatus and ... has been applied in the Gene Pulser II ... design of the Gene Pulser II system has ... has the widest range of settings to target ...
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
... Experion Pro260 reagents and supplies, ... and supplies sufficient to perform protein ... Experion automated electrophoresis system. Supplied are ... 45 microliters Pro260 stain, 60 microliters ...
... 3000 drug discovery system miniaturizes, integrates ... Using LabChip technology, the LabChip ... serial, continuous flow fashion. LabChip assays ... results exceeds what is achievable in ...
Biology Products: